Cargando…
Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
Empagliflozin (EMPA) therapy has led to improvements in patients with non-alcoholic fatty liver disease (NAFLD). Sestrin2 is a stress-inducible protein that controls the AMPK-mTOR pathway and inhibits oxidative damage in cells. This study investigated the functional implications of EMPA on the multi...
Autores principales: | Ma, Yuting, Zhang, Guangdong, Kuang, Zenggguang, Xu, Qian, Ye, Tongtong, Li, Xue, Qu, Na, Han, Fang, Kan, Chengxia, Sun, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483033/ https://www.ncbi.nlm.nih.gov/pubmed/36133815 http://dx.doi.org/10.3389/fphar.2022.944886 |
Ejemplares similares
-
Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells
por: Qu, Na, et al.
Publicado: (2022) -
Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Ma, Yuting, et al.
Publicado: (2021) -
Evaluation of Sestrin 2, Adiponectin, AMPK, and mTOR Genes Expression in Acute Myeloid Leukemia Patients
por: Abtahi, Seyed Hossein, et al.
Publicado: (2021) -
Integrated multi-omics analyses reveal effects of empagliflozin on intestinal homeostasis in high-fat-diet mice
por: Shi, Junfeng, et al.
Publicado: (2022) -
Cigarette smoke exposure induces ROS-mediated autophagy by regulating
sestrin, AMPK, and mTOR level in mice
por: Morsch, Ana Lucia Bernardo Carvalho, et al.
Publicado: (2019)